Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Lipodystrophies
ADR ID BADD_A02556
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.07      Skin and subcutaneous tissue disorders NEC
23.07.01      Lipodystrophies
Description A collection of heterogenous conditions resulting from defective LIPID METABOLISM and characterized by ADIPOSE TISSUE atrophy. Often there is redistribution of body fat resulting in peripheral fat wasting and central adiposity. They include generalized, localized, congenital, and acquired lipodystrophy. [MeSH]
MedDRA Code 10024606
MeSH ID D008060
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE)
Synonym
Lipodystrophy | Lipodystrophies
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Cellular retinoic acid-binding protein 1P29762Not Available
Cytochrome P450 3A43Q9HB55Not Available
Low-density lipoprotein receptor-related protein 11Q86VZ4Not Available
Peroxisome proliferator-activated receptor gammaP37231T58921
Retinoic acid receptor RXR-alphaP19793T13726
Drugs Leading to the ADR
Drug IDDrug Name
BADD_D00008Abacavir
BADD_D00066Alendronic acid
BADD_D00136Amprenavir
BADD_D00174Asfotase alfa
BADD_D00176Atazanavir
BADD_D00306Budesonide
BADD_D00490Clobetasol propionate
BADD_D00586Darunavir
BADD_D00603Delavirdine
BADD_D00661Didanosine
BADD_D00704Dolutegravir sodium
BADD_D00749Efavirenz
BADD_D00766Emtricitabine
BADD_D00857Etravirine
BADD_D00898Finasteride
BADD_D00917Fludrocortisone
BADD_D00918Fludrocortisone acetate
BADD_D00961Fosamprenavir calcium
BADD_D01020Glatiramer
BADD_D01021Glatiramer acetate
BADD_D01150Indinavir
BADD_D01159Insulin (human)
BADD_D01160Insulin aspart
BADD_D01161Insulin degludec
BADD_D01162Insulin detemir
BADD_D01163Insulin glargine
BADD_D01164Insulin glulisine
BADD_D01165Insulin lispro
BADD_D01242Lamivudine
BADD_D01352Maraviroc
The 1th Page    1 2    Next   Last    Total 2 Pages